Adani, Apollo Hospital Eye Stake In Metropolis Healthcare
In this episode, find out Tata Power’s plans to partner with Kolte Patil Developers for EV stations, also find out about NCLT’s decision to hear Amazon’s petition against insolvency of Future Retail on June 10
Available Episodes Newest First Oldest First EPISODE 669 15 Oct 2024 How Akasa’s Vinay Dube is taking on a duopoly; Class action lawsuits rise in India Read more
How Akasa’s Vinay Dube is taking on a duopoly; Class action lawsuits rise in India Read more
EPISODE 668 14 Oct 2024 Is the economy slowing down? Meta in CCI’s crosshairs Read more
Is the economy slowing down? Meta in CCI’s crosshairs Read more
EPISODE 667 11 Oct 2024 Indian markets finally hit a wall? Read more
Indian markets finally hit a wall? Read more
EPISODE 666 10 Oct 2024 Understanding RBI's MPC decision, Kalyani family's legal battle Read more
Understanding RBI's MPC decision, Kalyani family's legal battle Read more
EPISODE 665 09 Oct 2024 Bigger TVs get cheaper, welcome back Hockey India League Read more
Bigger TVs get cheaper, welcome back Hockey India League Read more
EPISODE 664 08 Oct 2024 Hero vs Honda, why Pujo might go by without any hilsa Read more
Hero vs Honda, why Pujo might go by without any hilsa Read more
EPISODE 663 07 Oct 2024 Making sense of last week's falling markets, how e-visas work Read more
Making sense of last week's falling markets, how e-visas work Read more
EPISODE 662 04 Oct 2024 MUFG is sole bidder for Yes Bank; Silver lining in India’s exports basket Read more
MUFG is sole bidder for Yes Bank; Silver lining in India’s exports basket Read more
EPISODE 661 03 Oct 2024 Google offers to settle antitrust case; Infosys to lead Indian IT pack this festive season Read more
Google offers to settle antitrust case; Infosys to lead Indian IT pack this festive season Read more
EPISODE 660 02 Oct 2024 Is luxury tourism in India just getting started? Liquor makers in crosshairs over surrogate ads Read more
Is luxury tourism in India just getting started? Liquor makers in crosshairs over surrogate ads Read more
